Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 274,619 Werewolf Therapeutics, Inc. shares (Form 4)

Traded Apr 30 to May 4, 2026 · Filed May 4, 2026

From Apr 30 to May 4, 2026, Luke Evnin (Director) sold 274,619 Werewolf Therapeutics, Inc. shares at an average US$0.72 for US$198K under a trading plan, leaving 1,679,330 shares. Filed May 4, 2026 (Form 4).

Sold
274,619 shares
Price
US$0.72 average (US$0.72 to US$0.73)
Value
US$198K
Holding after
1,679,330 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockSale168,262US$0.721,785,687Indirect
May 1, 2026Common StockSale58,394US$0.731,727,293Indirect
May 4, 2026Common StockSale47,963US$0.721,679,330Indirect

Source

View original at SEC

Related